Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines

NCT07061847 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT07061847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07061847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
Lead sponsor
Northwell Health
Phase
Phase 2
Overall status
Recruiting
Start date
March 10, 2025
Completion date
June 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine